Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB.

Functional analysis of -351 interleukin-9 promoter polymorphism reveals an activator controlled by NF-kappaB.
复制标题

DOI:
10.1038/gene.2009.28
复制
发表时间:
2009-06
期刊:
影响因子:
5
通讯作者:
Steinke, J. W.
Steinke, J. W.
中科院分区:
医学3区
文献类型:
--
作者:
Early, S. B.;Huyett, P.;Brown-Steinke, K.;Borish, L.;Steinke, J. W.

文献摘要

参考文献

被引文献

相似文献

遗传学研究表明,哮喘与人类染色体5q31-q33区域有关,其中包括IL-9基因。在IL-9启动子的bp -351处发现了A-to-G碱基取代。这种多态性在IL-9启动子功能中的作用是利用从具有一个或两个G等位基因的个体中纯化的CD4+ T细胞来评估的,与野生型A的纯合子相比,-351 (A等位基因)的A的存在使有丝分裂原刺激的IL-9转录增加了2倍,与在该位置具有一个或两个G等位基因的受试者相比。从产生il -9的人类细胞系中提取的核提取物蛋白与DNA序列的结合,包括这种碱基交换,证明了转录因子NF-κB的特异性结合。利用染色质免疫沉淀法在体内证实了NF-κB与IL-9启动子的结合。重组NF-κB与a等位基因启动子片段结合的亲和力比与G等位基因启动子片段高5倍。携带IL-9启动子A等位基因的个体显示IL-9合成增加,这可能导致强烈的Th2免疫反应,并调节其对感染性、肿瘤性、寄生虫性或特应性疾病的易感性。
Genetic studies have shown linkages for asthma to the chromosomal region 5q31-q33 in humans that includes the IL-9 gene. An A-to-G base substitution has been identified at bp -351 in the IL-9 promoter. The role of this polymorphism in IL-9 promoter function was assessed utilizing CD4+ T cells purified from individuals with one or two of the G alleles in comparison to those homozygous for the wild type A. The presence of an A at -351 (A allele) increased mitogen-stimulated IL-9 transcription 2-fold in comparison to subjects with one or 2 G alleles at this position. Binding of nuclear extract proteins from IL-9-producing human cell lines to DNA sequences including this base exchange demonstrated specific binding of the transcription factor NF-κB. Binding of NF-κB to the IL-9 promoter was confirmed in vivo using the chromatin immunoprecipitation assay. Recombinant NF-κB bound to a promoter fragment with the A allele with 5 fold higher affinity than it did to a promoter with the G allele. Individuals carrying the A allele of the IL-9 promoter display increased synthesis of IL-9, which may result in strong Th2 immune responses and a modulation of their susceptibility to infectious, neoplastic, parasitic, or atopic disease.
DOI: 10.1111/j.1600-0609.2005.00613.x
发表时间: 2006-04-01
影响因子: 3.1
作者:
Glimelius, I;Edström, A;Molin, D
通讯作者: Molin, D
DOI: 10.1002/jlb.57.3.353
发表时间: 1995-03-01
影响因子: 5.5
作者:
RENAULD, JC;KERMOUNI, A;VANSNICK, J
通讯作者: VANSNICK, J
DOI: 10.4049/jimmunol.166.7.4391
发表时间: 2001-04-01
影响因子: 4.4
作者:
Stassen, M;Müller, C;Schmitt, E
通讯作者: Schmitt, E
DOI: 10.4049/jimmunol.167.10.5838
发表时间: 2001-11-15
影响因子: 4.4
作者:
LeVan, TD;Bloom, JW;Vercelli, D
通讯作者: Vercelli, D
DOI: 10.1002/eji.1830271011
发表时间: 1997-10-01
影响因子: 5.4
作者:
Faulkner, H;Humphreys, N;Grencis, R
通讯作者: Grencis, R